Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle‐Invasive Bladder Cancer Treated With Radical CystectomyShingo Hatakeyama, Rikiya Taoka, Jun Miki et al.|Cancer Medicine|2025Cited by 8
Stage <scp>III</scp> substaging and outcomes in patients with bladder cancer undergoing radical cystectomyShuhei Hara, Wataru Fukuokaya, Jun Miki et al.|International Journal of Urology|2025Cited by 7
Multi-institutional retrospective analysis of learning curves on dosimetry and operation time before and after introduction of intraoperatively built custom-linked seeds in prostate brachytherapyHiromichi Ishiyama, Kazushige Hayakawa, Koji Okihara et al.|Journal of Radiation Research|2015Cited by 7
Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohortRyoichi Saito, Rikiya Taoka, Jun Miki et al.|International Journal of Clinical Oncology|2025Cited by 5
Reproductive organ involvement in women undergoing radical cystectomy for urothelial bladder cancer: a nationwide multicenter studyMinoru Kato, Rikiya Taoka, Jun Miki et al.|International Journal of Clinical Oncology|2024Cited by 3